Latest filing published 08 Jul 2026 for Larimar Therapeutics, Inc., €146k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Thomas Edward Hamilton span 2 companies, the busiest being Larimar Therapeutics, Inc. and Annaly Capital Management Inc. Over a trading history stretching from 3 May 2021 to 6 July 2026, the count stands at 6 filings.
On the open market, the record shows 5 purchases worth €2.5M and 1 sale worth €609k. Purchases outweigh sales by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 2 purchases and no sales on the market.
Half of the purchases are above €424k and half below. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 8 July 2026: an open-market purchase of €146k, in Larimar Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations